A disease activity score for polymyalgia rheumatica

Annals of the Rheumatic Diseases

Volumn 63, Issue 10, 2004, Pages 1279-1283

  Leeb, B F ^a   Bird, H A ^b  

^a Lower Austrian Center for Rheumatology   (Austria)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; AUSTRIA; CALCULATION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PATIENT MONITORING; PATIENT SATISFACTION; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; SCORING SYSTEM; TREATMENT OUTCOME; VALIDATION PROCESS;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; HUMANS; LINEAR MODELS; MIDDLE AGED; PATIENT SATISFACTION; POLYMYALGIA RHEUMATICA; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 4644236004     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.011379     Document Type: Article

References (18)

1. Epperly TD, Moore KE, Harrover JD. Polymyalgia rheumatica and temporal arteritis. Fam Physician 2000;62:789-96.
2. Cimmino MA, Zaccaria A. Epidemiology of polymyalgia rheumatica. Clin Exp Rheumatol 2000;18(suppl 20):S9-11.
3. Whittaker PE, Fitzsimmons MG. A 24-year-old man with symptoms and signs of polymyalgia rheumatica. J Fam Pract 1998;47:68-71.
4. Weyand C, Fulbright JW, Evans JM, Hunder GG, Goronzy JJ. Corticosteroid requirements in polymyalgia rheumatica. Arch Intern Med 1999;159:577-84.
5. Proven A, Gabriel SE, O'Fallon WM, Hunder GG. Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis. J Rheumatol 1999;26:1333-7.
6. Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979;38:434-9.
7. Jones JG, Hazleman BL. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis 1981;40:1-5.
8. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982;97:672-80.
9. Wilke WS, Wysenbeek AJ, Krall PL, Segal AM. Masked presentation of giant-cell arteritis. Cleve Clin Q 1985;52:155-9.
10. Nobunaga M, Yoshioka K, Yasuda M, Shingu M. Clinical studies of polymyalgia rheumatica. A proposal of diagnostic criteria. Jpn J Med 1989;28:452-6.
11. Leeb BF, Bird HA, Nesher G, Andel I, Hueber W, Logar D, et al. EULAR response criteria for polymyalgia rheumatica. Results of an initiative of the European collaborating Polymyalgia Rheumatica group (Subcommittee of ESCISIT (EULAR Standing Committee on Clinical Trials Including Therapeutical Trials)). Ann Rheum Dis 2003;62:1189-94.
12. Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003;42:244-57.
13. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
14. Furst DE, Breedveld FC, Kalden JR, Smolen JS, Antoni CE, Bijlsma JW, et al. Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002). Ann Rheum Dis 2001;61(suppl II):ii2-7.
15. Streiner DL. Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Personality Assessment 2003;80:99-103.
16. Kyle V, Cawston TE, Hazleman BL. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis 1989;48:667-71.
17. Gonzalez-Gay MA, Rodriguez-Valverde V, Blanco R, Fernandez-Sueiro JL, Armona J, Figueroa M, et al. Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate. A more benign syndrome. Arch Intern Med 1997;157:317-20.
18. Cantini F, Salvarani C, Olivieri I, Macchioni L, Ranzi A, Niccoli L, et al. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study. Semin Arthritis Rheum 2000;30:17-24.